MMDA-2: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
'''MMDA-2''' is a [[psychedelic drug]] and a [[substituted amphetamine]]. It is a member of the [[methylenedioxyphenethylamine]] class and is chemically related to [[MDMA]] and [[MMDA]].
== MMDA-2 ==


== History ==
[[File:MMDA-2-structure.png|thumb|right|Chemical structure of MMDA-2]]


MMDA-2 was first synthesized by [[Alexander Shulgin]], a renowned American medicinal chemist and psychopharmacologist. Shulgin documented his findings in his book ''[[PiHKAL]]: A Chemical Love Story'', where he described the effects of MMDA-2 as being similar to MMDA, but with a longer duration.
'''MMDA-2''' (3-methoxy-4,5-methylenedioxyamphetamine) is a psychedelic drug of the [[amphetamine]] class. It is a derivative of [[MMDA]] and is known for its psychoactive effects. MMDA-2 is structurally related to other compounds such as [[MDA]] and [[MDMA]], which are also known for their psychoactive properties.


== Chemistry ==
== Chemical Structure ==


MMDA-2 is a [[phenethylamine]] derivative with a methylenedioxy group attached to the benzene ring. It is structurally similar to other psychedelic phenethylamines such as [[mescaline]] and [[2C-B]]. The compound is chiral, and the S-isomer is the more active form.
MMDA-2 is characterized by the presence of a methoxy group at the 3-position and a methylenedioxy group at the 4,5-positions of the phenyl ring. This structure is similar to that of other [[phenethylamines]], which are known to interact with the [[serotonin]] system in the brain.


== Pharmacology ==
== Pharmacology ==


The exact mechanism of action of MMDA-2 is not fully understood. However, it is believed to act as a [[serotonin receptor]] agonist, similar to other psychedelic drugs. It may also have activity at other receptor sites in the brain.
MMDA-2 acts primarily as a [[serotonin receptor]] agonist, which is believed to be responsible for its psychedelic effects. The compound is thought to increase the release of serotonin and inhibit its reuptake, leading to altered perception, mood, and cognition.


== Effects ==
== Effects ==


The effects of MMDA-2 are reported to be similar to those of other psychedelic drugs, including altered perception, enhanced visual and auditory sensations, and introspective experiences. The duration of effects is typically longer than that of MMDA, lasting up to 12 hours.
The effects of MMDA-2 are similar to those of other psychedelic amphetamines. Users report changes in visual perception, mood elevation, and altered thought processes. The duration of effects typically lasts several hours, depending on the dose and individual metabolism.


== Legal Status ==
== Legal Status ==


The legal status of MMDA-2 varies by country. In the United States, it is classified as a [[Schedule I drug]] under the [[Controlled Substances Act]], meaning it has a high potential for abuse and no accepted medical use.
The legal status of MMDA-2 varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important to be aware of the legal implications of possessing or using MMDA-2 in your jurisdiction.


== See Also ==
== Related Compounds ==


* [[MMDA]]
* [[MDA]]
* [[MDMA]]
* [[2C-B]]
== Related Pages ==
* [[Psychedelic drug]]
* [[Amphetamine]]
* [[Serotonin]]
* [[Phenethylamine]]
* [[Phenethylamine]]
* [[Psychedelic drug]]
* [[Alexander Shulgin]]
* [[PiHKAL]]


[[Category:Psychedelic drugs]]
[[Category:Psychedelic drugs]]
[[Category:Substituted amphetamines]]
[[Category:Amphetamines]]
[[Category:Phenethylamines]]
{{Psychoactive drug-stub}}

Latest revision as of 03:37, 13 February 2025

MMDA-2[edit]

Chemical structure of MMDA-2

MMDA-2 (3-methoxy-4,5-methylenedioxyamphetamine) is a psychedelic drug of the amphetamine class. It is a derivative of MMDA and is known for its psychoactive effects. MMDA-2 is structurally related to other compounds such as MDA and MDMA, which are also known for their psychoactive properties.

Chemical Structure[edit]

MMDA-2 is characterized by the presence of a methoxy group at the 3-position and a methylenedioxy group at the 4,5-positions of the phenyl ring. This structure is similar to that of other phenethylamines, which are known to interact with the serotonin system in the brain.

Pharmacology[edit]

MMDA-2 acts primarily as a serotonin receptor agonist, which is believed to be responsible for its psychedelic effects. The compound is thought to increase the release of serotonin and inhibit its reuptake, leading to altered perception, mood, and cognition.

Effects[edit]

The effects of MMDA-2 are similar to those of other psychedelic amphetamines. Users report changes in visual perception, mood elevation, and altered thought processes. The duration of effects typically lasts several hours, depending on the dose and individual metabolism.

Legal Status[edit]

The legal status of MMDA-2 varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important to be aware of the legal implications of possessing or using MMDA-2 in your jurisdiction.

Related Compounds[edit]

Related Pages[edit]